Jazz Pharmaceuticals plc

NASDAQ: JAZZ
$125.10
+$5.86 (+4.9%)
Closing Price on November 21, 2024

JAZZ Stock Chart and Intraday Price

JAZZ Stock Data

Asset Type Stock
Exchange NASDAQ
Currency USD
Country USA
Sector LIFE SCIENCES
Industry PHARMACEUTICAL PREPARATIONS
Address FIFTH FLOOR, WATERLOO EXCHANGE, WATERLOO ROAD, DUBLIN, IE
Fiscal Year End December
Latest Quarter 12/31/2023
Market Cap 7,482.43M USD
Shares Outstanding 62,957,000
Jazz Pharmaceuticals plc is a global biopharmaceutical company focused on developing and marketing innovative medicines to meet significant unmet medical needs. With a diverse portfolio, Jazz Pharmaceuticals offers treatments for narcolepsy, epilepsy, cancer, and acute leukemia among other serious conditions. Their products include Xywav, Xyrem, Epidiolex, and Zepzelca, addressing issues from sleep disorders to severe forms of epilepsy and cancer. Headquartered in Dublin, Ireland, Jazz Pharmaceuticals is committed to improving patients' lives through science, with ongoing research in neurological disorders and oncology.

JAZZ Articles

Invest Alongside Wall Street Legend Seth Klarman: 2 New Stocks He Bought and 1 He Dumped
Enigmatic investing legend Seth Klarman runs the Boston-based Baupost Group hedge fund that has around $27 billion in assets under management.  The billionaire is a value investor in the vein of...
Rich Duprey
Published:

Add These 5 Hot Biotech Stocks In July
Investing in biotech stocks can be rewarding. Not just because these stocks have the potential to produce meaningful gains in your portfolio, but also because when you invest in them, you’re...
Joshua Rodriguez
Published:

Tuesday's Top Analyst Upgrades and Downgrades: Bill, Carnival, Oracle, Palantir, Petrobras, Valvoline, Walmart and More
Tuesday's top analyst upgrades and downgrades included Bill, Carnival, CenterPoint Energy, Editas Medicine, International Paper, Oracle, Palantir Technologies, Petrobras, SentinelOne, Trade Desk,...
Lee Jackson
Published:

Wednesday's Top Analyst Upgrades and Downgrades: AutoZone, Etsy, Luminar, Nike, Norwegian Cruise, PayPal, Western Digital, Weyerhaeuser and More
Wednesday's top analyst upgrades and downgrades included AutoZone, EOG Resources, Etsy, Huntsman, Luminar Technologies, Nike, Norwegian Cruise Line, PayPal, Pioneer Natural Resources, Western Digital...
Lee Jackson
Published:

Wednesday's Top Analyst Upgrades and Downgrades: Chesapeake Energy, eBay, Hewlett Packard Enterprise, Oracle, Phillips 66, US Steel and More
Wednesday's top analyst upgrades and downgrades included Accenture, Bridgebio Pharma, Chesapeake Energy, eBay, Hewlett Packard Enterprise, Huntsman, New York Community Bancorp, Nucor, Oracle, PBF...
Lee Jackson
Published:

New Era of the Activist Investor, and More Analyst Upgrades and Downgrades: AbbVie, Bristol-Myers, JetBlue and More
Wednesday’s additional top analyst upgrades and downgrades included AbbVie, Bristol-Myers, JetBlue, and more.
Chris Lange
Published:

Monday's Top Analyst Upgrades and Downgrades: Chevron, Eli Lilly, Halliburton, Home Depot, Microsoft, Robinhood Markets, Southwest Air and More
Monday's top analyst upgrades and downgrades included Adobe, Anheuser-Busch, Baker Hughes, Chevron, Eli Lilly, Halliburton, Home Depot, Intuit, Microsoft, Robinhood Markets, Shopify, Sirius XM,...
Lee Jackson
Published:

Tuesday's Top Analyst Upgrades and Downgrades: Albertsons, Charles Schwab, CyberArk, Deckers Outdoor, Nike, Procter & Gamble, Tesla and More
Tuesday's top analyst upgrades and downgrades included Albertsons, Charles Schwab, Colgate-Palmolive, CyberArk Software, Deckers Outdoor, Dow, Lordstown Motors, Nike, Procter & Gamble and Tesla.
Lee Jackson
Published:

Thursday's Top Analyst Upgrades and Downgrades: Amgen, Biogen, Commscope, Lockheed Martin, ONEOK, Plug Power, Roku and More
Thursday's top analyst upgrades and downgrades included Amgen, Biogen, Commscope, Lockheed Martin, Northrop Grumman, ONEOK, Plug Power and Roku.
Lee Jackson
Published:

Abercrombie, Pfizer, Teva and More of Wednesday Afternoon Analyst Calls
24/7 Wall St. looks at some big analyst calls that we have seen so far on Wednesday, including Abercrombie & Fitch, Pfizer and Teva Pharmaceutical.
Chris Lange
Published:

Jefferies Top Growth Stocks to Buy Include 2 Red-Hot Sports Betting Winners
These four Jefferies growth stock picks for more aggressive investors all have significant catalysts to drive growth the rest of 2021 and beyond. Two of them are red-hot companies cashing in on...
Lee Jackson
Published:

Biogen, Fortinet, Kohl's, Pinterest, Snap and More Friday Afternoon Analyst Calls
The Friday afternoon analyst calls were focused on Biogen, Fortinet, Pinterest, Snap and more.
Chris Lange
Published:

Cannabis-Derived Drug Maker GW Pharma Acquired by Jazz Pharma for $7.2 Billion
London-based Jazz Pharmaceuticals has agreed to pay $7.2 billion to acquire GW Pharmaceuticals, a maker of drugs derived from cannabis plants.
Paul Ausick
Published:

Top Analyst Upgrades and Downgrades: Chipotle, Etsy, Exxon, GE, Jazz Pharmaceuticals, Microsoft, Nikola, Palo Alto, Pfizer, Twitter and More
Wednesday's top analyst upgrades and downgrades included Chipotle Mexican Grill, Etsy, Exxon Mobil, General Electric, Jazz Pharmaceuticals, Microsoft, Nikola, Palo Alto Networks, Pfizer and Twitter.
Lee Jackson
Published:

BofA Securities Top 10 US Stock Ideas for the Rest of 2021
BofA Securities has released its top ideas for the rest of 2021. Here are eight top long ideas and two potential shorts for more aggressive investors.
Lee Jackson
Published:
Last Updated: